HuGE Literature Finder
Records 1-30
|
Cisplatin +/- rucaparib after preoperative chemotherapy in patients with triple-negative or BRCA mutated breast cancer.
NPJ breast cancer 2021 Mar 7 (1): 29. Kalra Maitri, Tong Yan, Jones David R, Walsh Tom, Danso Michael A, Ma Cynthia X, Silverman Paula, King Mary-Claire, Badve Sunil S, Perkins Susan M, Miller Kathy |
|
Combined breast conservation therapy versus mastectomy for BRCA mutation carriers - A systematic review and meta-analysis.
Breast (Edinburgh, Scotland) 2021 Feb 56 26-34. Davey M G, Davey C M, Ryan É J, Lowery A J, Kerin M |
|
Liquid Biopsy Cell-free DNA Biomarkers in Patients With Oligometastatic Colorectal Cancer Treated by Ablative Radiotherapy.
Anticancer research 2021 Feb 41 (2): 829-834. Nakamura Masaki, Kageyama Shun-Ichiro, Seki Masahide, Suzuki Ayako, Okumura Masayuki, Hojo Hidehiro, Motegi Atsushi, Akimoto Tets |
|
Locoregional treatments and ipsilateral breast cancer recurrence rates in BRCA1/2 mutation carriers.
International journal of radiation oncology, biology, physics 2020 Nov . Bernstein-Molho Rinat, Laitman Yael, Galper Shira, Jacobson Galia, Boursi Ben, Gal-Yam Einav Nili, Kaufman Bella, Friedman Eitan, Kaidar-Person Or |
|
Impact of the addition of carboplatin to anthracycline-taxane-based neoadjuvant chemotherapy on survival in BRCA1/2-mutated triple-negative breast cancer.
International journal of cancer 2020 Jul . Zhang Juan, Yao Lu, Liu Yiqiang, Ouyang Tao, Li Jinfeng, Wang Tianfeng, Fan Zhaoqing, Fan Tie, Lin Benyao, Xie Yunt |
|
Contralateral breast cancer and tumor recurrence in BRCA1/2 carriers and non-carriers at a high risk of hereditary breast cancer after bilateral mastectomy.
Cirugia espanola 2020 Jun . Allué Cabañuz Marta, Domingo Bretón María, Chóliz Ezquerro Jorge, Arribas Del Amo María Dolores, Güemes Sánchez Antonio Tom |
|
BRCA Mutation Association with Recurrence Score and Discordance in a Large Oncotype Database.
Oncology 2020 Jan 1-4. Blanter Julia, Zimmerman Brittney, Tharakan Serena, Ru Meng, Cascetta Krystal, Tiersten A |
|
Outcomes and risk of subsequent breast events in breast-conserving surgery patients with BRCA1 and BRCA2 mutation.
Cancer medicine 2020 Jan . Ye Fugui, Huang Liang, Lang Guantian, Hu Xin, Di Genhong, Shao Zhimin, Cao Ayo |
|
Clinical Evaluation of BRCA1/2 Mutation in Mexican Ovarian Cancer Patients.
Translational oncology 2019 Dec 13 (2): 212-220. Gallardo-Rincón Dolores, Álvarez-Gómez Rosa María, Montes-Servín Edgar, Toledo-Leyva Alfredo, Montes-Servín Elizabeth, Michel-Tello David, Alamilla-García Gabriela, Bahena-González Antonio, Hernández-Nava Elizabeth, Fragoso-Ontiveros Veronica, Espinosa-Romero Raquel, Cetina-Pérez Luce |
|
Identification of novel mutations of ovarian cancer-related genes from RNA-sequencing data for Japanese epithelial ovarian cancer patients.
Endocrine journal 2019 Nov . Nagasawa Saya, Ikeda Kazuhiro, Horie-Inoue Kuniko, Sato Sho, Takeda Satoru, Hasegawa Kosei, Inoue Satos |
|
Patterns of recurrence and metastasis in BRCA1/BRCA2-associated breast cancers.
Cancer 2019 Oct . Song Yun, Barry William T, Seah Davinia S, Tung Nadine M, Garber Judy E, Lin Nancy |
|
Germline mutation in DNA-repair genes is associated with poor survival in BRCA1/2-negative breast cancer patients.
Cancer science 2019 Aug . Fan Zhenhua, Hu Li, Ouyang Tao, Li Jinfeng, Wang Tianfeng, Fan Zhaoqing, Fan Tie, Lin Benyao, Xu Ye, Xie Yunt |
|
Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in
Cancers 2019 May 11 (6): . Vocka Michal, Zimovjanova Martina, Bielcikova Zuzana, Tesarova Petra, Petruzelka Lubos, Mateju Martin, Krizova Ludmila, Kotlas Jaroslav, Soukupova Jana, Janatova Marketa, Zemankova Petra, Kleiblova Petra, Novotny Jan, Konopasek Bohuslav, Chodacka Martina, Brychta Milan, Sochor Marek, Smejkalova-Musilova Denisa, Cmejlova Vlastimila, Kozevnikovova Renata, Miskarova Lenka, Argalacsova Sona, Stolarova Lenka, Lhotova Klara, Borecka Marianna, Kleibl Zden |
|
Analysis of Outcomes in Patients With BRCA1/2 Breast Cancer Mutations Treated With Accelerated Partial Breast Irradiation (APBI).
American journal of clinical oncology 2019 Apr . Ahmed Faisal, Christos Paul J, Singh Prabhsimranjot, Parashar Bhupesh, Wernicke Alla Gabriel |
|
Prevalence of germline variants in inflammatory breast cancer.
Cancer 2019 Apr . Rana Huma Q, Sacca Rosalba, Drogan Christine, Gutierrez Stephanie, Schlosnagle Emily, Regan Meredith M, Speare Virginia, LaDuca Holly, Dolinsky Jill, Garber Judy E, Overmoyer Beth |
|
Risk of ipsilateral breast tumor recurrence in primary invasive breast cancer following breast-conserving surgery with BRCA1 and BRCA2 mutation in China.
Breast cancer research and treatment 2019 Mar . Cao Wei, Xie Yuntao, He Yingjian, Li Jinfeng, Wang Tianfeng, Fan Zhaoqing, Fan Tie, Ouyang T |
|
BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
Molecular genetics & genomic medicine 2019 Jan . Liu Yan, Ide Yoshimi, Inuzuka Mayuko, Tazawa Sakiko, Kanada Yoko, Matsunaga Yuki, Kuwayama Takashi, Sawada Terumasa, Akashi-Tanaka Sadako, Nakamura Sei |
|
Somatic aberrations of BRCA1 gene are associated with ALDH1, EGFR, and tumor progression in prostate cancer.
International journal of cancer 2019 02 144 (3): 607-614. Omari Aleksandra, Nastaly Paulina, Stoupiec Sara, Balabas Aneta, Dabrowska Michalina, Bielinska Beata, Huss Sebastian, Pantel Klaus, Semjonow Axel, Eltze Elke, Brandt Burkhard, Bednarz-Knoll Natal |
|
BRCA1/BRCA2 Mutations Shaped by Ancient Consanguinity Practice in Southern Mediterranean Populations
Asian Pacific journal of cancer prevention : APJCP 2018 Oct 19 (10): 2963-2972. Belaiba Fadoua, Medimegh Imene, Bidet Yannick, Boussetta Sami, Baroudi Olfa, Mezlini Amel, Bignon Yves Jean, Benammar El gaaied Am |
|
RAD50 germline mutations are associated with poor survival in BRCA1/2-negative breast cancer patients.
International journal of cancer 2018 Oct 143 (8): 1935-1942. Fan Cong, Zhang Juan, Ouyang Tao, Li Jinfeng, Wang Tianfeng, Fan Zhaoqing, Fan Tie, Lin Benyao, Xie Yunt |
|
Associations between RAD51D germline mutations and breast cancer risk and survival in BRCA1/2-negative breast cancers.
Annals of oncology : official journal of the European Society for Medical Oncology 2018 Aug . Chen X, Li Y, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie |
|
Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers.
British journal of cancer 2018 Jun . Guiu Séverine, Mollevi Caroline, Charon-Barra Céline, Boissière Florence, Crapez Evelyne, Chartron Elodie, Lamy Pierre-Jean, Gutowski Marian, Bourgier Céline, Romieu Gilles, Simony-Lafontaine Joelle, Jacot Willi |
|
Subsequent breast and high grade serous carcinomas after risk-reducing salpingo-oophorectomy in BRCA mutation carriers and patients with history of breast cancer.
Annals of diagnostic pathology 2018 Jun 36 28-30. Straub Melissa M, Podoll Mirna B, David Stephanie N, Wiesner Georgia L, Desouki Mohamed |
|
The role of PARP inhibition in triple-negative breast cancer: Unraveling the wide spectrum of synthetic lethality.
Cancer treatment reviews 2018 May 67 34-44. Papadimitriou Marios, Mountzios Giannis, Papadimitriou Christos |
|
Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study.
The Lancet. Oncology 2018 Jan . Copson Ellen R, Maishman Tom C, Tapper Will J, Cutress Ramsey I, Greville-Heygate Stephanie, Altman Douglas G, Eccles Bryony, Gerty Sue, Durcan Lorraine T, Jones Louise, Evans D Gareth, Thompson Alastair M, Pharoah Paul, Easton Douglas F, Dunning Alison M, Hanby Andrew, Lakhani Sunil, Eeles Ros, Gilbert Fiona J, Hamed Hisham, Hodgson Shirley, Simmonds Peter, Stanton Louise, Eccles Diana |
|
The Use of Sentinel Lymph Node Biopsy in BRCA1/2 Mutation Carriers Undergoing Prophylactic Mastectomy: A Retrospective Consecutive Case-Series Study.
International journal of breast cancer 2018 2018 1426369. Câmara Sara, Pereira Daniela, André Saudade, Mira Beatriz, Vaz Fátima, Oom Rodrigo, Marques José Carlos, Leal de Faria João, Rodrigues Dos Santos Catari |
|
A functional BRCA1 coding sequence genetic variant contributes to prognosis of triple-negative breast cancer, especially after radiotherapy.
Breast cancer research and treatment 2017 Nov 166 (1): 109-116. Shi Meng, Ma Fei, Liu Jibing, Xing Huaixin, Zhu Hui, Yu Jinming, Yang Mi |
|
The role of BRCA status on prognosis in patients with triple-negative breast cancer.
Oncotarget 2017 Oct 8 (50): 87151-87162. Xie Yuxin, Gou Qiheng, Wang Qianqian, Zhong Xiaorong, Zheng Ho |
|
Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx.
International journal of cancer 2017 Jun . Zhu Lijun, Sturgis Erich M, Zhang Hua, Lu Zhongming, Tao Ye, Wei Qingyi, Li Guoj |
|
Young Israeli women with epithelial ovarian cancer: prevalence of BRCA mutations and clinical correlates.
Journal of gynecologic oncology 2017 Jun . Helpman Limor, Zidan Omri, Friedman Eitan, Kalfon Sarit, Perri Tamar, Ben-Baruch Gilad, Korach Jac |
- Page last reviewed:Oct 1, 2020
- Page last updated:May 05, 2021
- Content source: